Biological and Clinical Relevance of H19 in Colorectal Cancer Patients
Open Access
- 8 November 2016
- journal article
- editorial
- Published by Elsevier BV in EBioMedicine
- Vol. 13, 9-10
- https://doi.org/10.1016/j.ebiom.2016.11.001
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal CancerEBioMedicine, 2016
- Evaluation of the Role of Circulating Long Non‐Coding RNA H19 as a Promising Novel Biomarker in Plasma of Patients with Gastric CancerJournal of Clinical Laboratory Analysis, 2016
- Long noncoding RNA H19 indicates a poor prognosis of colorectal cancer and promotes tumor growth by recruiting and binding to eIF4A3Oncotarget, 2016
- Long noncoding RNA H19 inhibits the proliferation of fetal liver cells and the Wnt signaling pathwayFEBS Letters, 2016
- The H19 Long non-coding RNA in cancer initiation, progression and metastasis – a proposed unifying theoryMolecular Cancer, 2015
- The Mediator complex: a central integrator of transcriptionNature Reviews Molecular Cell Biology, 2015
- Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expressionCancer Letters, 2013
- A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?Cell, 2011
- Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancerCarcinogenesis: Integrative Cancer Research, 2009
- The product of the H19 gene may function as an RNA.Molecular and Cellular Biology, 1990